Abacus Health Products, Inc. is a company engaged in the development and commercialization of over-the-counter (OTC) topical pain-relieving medications which contain organic and natural ingredients, including CBD, a cannabinoid-rich hemp extract from Cannabis sativa L plant. Abacus products combine science with organic and natural ingredients to provide effective and safe pain relief. Abacus’ products are aimed at the rapidly growing market for topical pain relief, are based on proprietary patent-pending technologies and are registered with the U.S. Food and Drug Administration.
Investor note: In addition to the 9,832,826 Subordinate Voting common shares that are listed and trading, there are 10,390,360 reserved for issuance pursuant to the conversion rights attached to the Proportionate Voting shares that are issued and outstanding but not listed. The total number of issued shares assuming all are converted into the listed class would be 20,223,186.